ampelopsin has been researched along with Alcoholic Fatty Liver in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Miyasaka, K; Shimizu, N; Shimoda, H; Takeda, S; Wu, J; Yamada, W | 1 |
Bhatti, AA; Davies, DL; Folk, C; Kim, P; Liang, J; Moradian, R; Silva, J; Spatz, MH; Yu, X | 1 |
2 other study(ies) available for ampelopsin and Alcoholic Fatty Liver
Article | Year |
---|---|
The Anti-Adiposity Mechanisms of Ampelopsin and Vine Tea Extract in High Fat Diet and Alcohol-Induced Fatty Liver Mouse Models.
Topics: 3T3-L1 Cells; Adiposity; Animals; Anti-Obesity Agents; Antioxidants; Diet, High-Fat; Fatty Liver, Alcoholic; Flavonoids; Lipid Metabolism; Lipogenesis; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Phytotherapy; Plant Extracts; Rats; Rats, Sprague-Dawley; Tea | 2022 |
Dihydromyricetin Protects the Liver via Changes in Lipid Metabolism and Enhanced Ethanol Metabolism.
Topics: Adenylate Kinase; Animals; Dietary Supplements; Enzyme Activation; Ethanol; Fatty Liver, Alcoholic; Flavonols; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Diseases, Alcoholic; Male; Mice; Mice, Inbred C57BL; Triglycerides | 2020 |